WindhoverV2.0
Home
Home
Register
Register
Login
Log In
Schedule
Schedule
Information
Info
Contact
Contact
Help
Help
November 28-30, 2012The Westin Copley PlaceBoston, MA

Grow the Value of your Assets through Financing, M & A and Strategic Partnerships


The 7th Annual Therapeutic Area Partnerships is a one-of-a-kind opportunity to assess some of the most promising drugs in development and available for partnering in the following areas:

Oncology • Cardiovascular/Metabolic diseases • Neuroscience • Infectious diseases • Autoimmune/Inflammatory Diseases • Hot Space
(Women's Health, Dermatology, Bone & Muscle Disease, Ophthalmology, Rare Diseases and other high value and niche areas)

TA Partnerships is the most targeted, efficient, and strategic-level partnering meeting for the biggest dealmakers seeking partnerships in hot therapeutic areas. At TA Partnerships you will meet fellow companies who are looking for exactly the assets you have to offer. The most active in-licensors and out-licensors will be available to create future growth through investments in partnership deals.


KEYNOTE LEADERSHIP ADDRESS:
Robert S. Langer

David H. Koch Institute Professor, MIT
Founder, 24+ Companies


Overcoming the Barriers to Biomedical Breakthroughs from Academia to Industry

  • Challenging conventional wisdom
  • Crossing disciplinary boundaries
  • Persisting in the face of failure
  • Building powerful intellectual property

OTHER HOT TOPICS INCLUDE:
Improving approaches to regulatory hurdles in clinical trials

Is Big Pharma really ready to advance smaller market products?

Pathways leading bioscience business to higher valuations

Solutions for the Crisis in Neurotherapeutics Productivity

The Top 10 Projects to Watch are chosen to present in each therapeutic area, and are hand-picked by a panel of independent experts who screen hundreds of compounds and weigh their potential as future products. Many presenting companies in previous years have gone on to establish major partnerships - QRxPharma, Vectura, AVEO, Trophos, BiPar, Myogen, Sirtris and Kosan – just to name a few.

Past Top 10 Candidates Signed a Total Potential value of $17 BILLION US in acquisitions and alliances. Don't miss out on potential opportunities!

Recent List of Past Top 10 Nominated Companies - Just a few samples of deal history:

Register to Attend